BIOFRONTERA AG NA O.N./ DE0006046113 /
| 2024-04-29 7:55:10 PM | Chg. +0.090 | Volume | Bid9:58:00 PM | Ask9:58:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 0.398EUR | +29.22% | 20,038 Turnover: 7,144.900 |
0.360Bid Size: 8,739 | 0.400Ask Size: 7,000 | 19.85 mill.EUR | 0.00% | 0.51 |
Fundamentals
| FY 2021 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 0.69 EUR | - |
| EPS Diluted: | 0.68 EUR | - |
| Revenues per Share: | 0.51 EUR | -19.98% |
| Book Value per Share: | 1.02 EUR | 559.84% |
| Cash Flow per Share: | 0.54 EUR | - |
| Dividend per Share: | 0.00 EUR | - |
| Total | in mill. | |
| Revenues: | 28.80 EUR | -4.95% |
| Net Income: | 38.30 EUR | - |
| Operating Cash Flow: | 30.40 EUR | - |
| Cash and Cash Equivalents: | 6.90 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 0.51 | 2.14 |
| P/S Ratio: | 0.69 | 2.91 |
| P/BV ratio: | 0.34 | 1.45 |
| P/CF Ratio: | 0.65 | 2.76 |
| PEG: | - | - |
| Earnings Yield: | 197.14% | 46.62% |
| Dividend Yield: | 0.00% | 0.00% |
| Market Capitalization | ||
| Market Capitalization: | 19.85 mill. EUR | 83.94 mill. EUR |
| Free Float Market Cap.: | 9.21 mill. EUR | 38.96 mill. EUR |
| Market Cap. / Employee: | 121,784.9693 EUR | 514,976.4417 EUR |
| Shares Outstanding: | 56.72 mill. | |
Profitability
| Gross Profit Margin: | 86.46% |
| EBIT Margin: | 85.76% |
| Net Profit Margin: | 132.99% |
| Return on Equity: | 66.03% |
| Return on Assets: | 49.93% |
Financial Strength
| Liquidity I / Cash Ratio: | 42.29% |
| Liquidity II / Quick Ratio: | 46.86% |
| Liquidity III / Current Ratio: | 82.29% |
| Debt / Equity Ratio: | 32.24% |
| Dynam. Debt / Equity Ratio: | 61.51% |
Efficiency
| Employees: | 163 |
| Personal Expenses / Employee: | 120,858.90 EUR |
| Revenues / Employee: | 176,687.12 EUR |
| Net Income / Employee: | 234,969.33 EUR |
| Total Assets / Employee: | 470,552.15 EUR |
| * Fiscal Year End: | 2021-12-31 |
| Accounting Standard: | IFRS |
| Currency: | EUR |
